Swanson Reed News

ASX listed healthcare company provides update on R&D Tax Dispute

August 10th, 2026

In May 2025, Careteq Limited (ASX: CTQ) a clinical healthtech company specialising in medication management and clinical governance solutions announced details of a disputed R&D claim. The May 2025 announcement noted that Careteq: ‘advises that it has been issued with amended assessments from the Australian Taxation Office (ATO) in relation to claims made under the Australian government’s Research and Development Research and Development Tax Incentive (R&D Tax Incentive)for the financial years ended 30 June 2021, 2022 and 2023 (Amended Assessments). The Amended […]

Read More

Updated ATO guidance on R&D activities conducted for an associated foreign corporation

August 3rd, 2026

The ATO has updated guidance on 13 July 2026 around the provisions for R&D activities conducted for an associated foreign corporation. To be eligible to claim the R&D tax incentive for R&D activities conducted for one or more associated foreign corporations, the following conditions must apply: Each foreign corporation must be a resident of a foreign country that has a double tax agreement with Australia. The R&D activity must be conducted solely in Australia or an external territory of Australia. If the R&D activity is a supporting […]

Read More

Recent media coverage over concerns for proposed 10 year limit to Refundable R&D Tax Offset Eligibility

July 13th, 2026

The Federal Budget handed down on 12 May 2026, The Government proposed major structural changes to the R&D Tax Incentive (RDTI). These changes are proposed to commence on 1 July 2028. Proposed reforms include: Increasing the offset for experimental ‘core’ R&D by around 25 to 50 per cent and removing eligibility for expenditure that only supports R&D. The intensity threshold will reduce from 2 per cent to 1.5 per cent, providing higher offsets to firms undertaking substantial core R&D. Expenditure on […]

Read More

Law now passed to exclude tobacco and gambling activities from eligibility under R&D Tax Incentive

July 2nd, 2026

The December 2024 Mid‑Year Economic and Fiscal Outlook (MYEFO) was released by the Government on 18 December 2024 and announced that The Government will exclude activities related to gambling and tobacco from Research and Development Tax Incentive eligibility for income years starting on or after 1 July 2025. This proposal can probably be linked to the transparency reporting of R&D claimants and public reaction regarding large claims made by gaming software companies.   The Government then released an exposure draft in December 2025, […]

Read More

Alex Chisholm
Principal, Melbourne
Tom Parkhouse
Principal, Sydney
Andy Nguyen
Principal, Brisbane
Holly Parkinson
Manager, Adelaide
David Greatwich
Principal, Perth
Krishna Gungaram
Manager, Hobart

Categories

Archives